Search results
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 2 hours agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 4 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 16 hours agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
California State Teachers Retirement System Increases Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 hours agoCalifornia State Teachers Retirement System grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 1.5% during the fourth quarter, according to its most recent 13F filing ...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 3 days agoBut it can be serious or even deadly in babies and older adults. Like rivals Pfizer and GSK — which...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 3 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoDuring the March quarter, the U...projection. The company also raised its sales outlook for the...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 3 days agovaccine trial. The company will present preliminary data, highlighting the potential of circulating tumour DNA in the early detection of colorectal...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 3 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
AOL· 3 days agoThe U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new ...